• Endometriosis Self-care: Skin Care Matters
  • Ozanimod Results Promising in Crohn’s Disease, Ulcerative Colitis, Phase 2 Trial Data Show
  • FDA to Review Lynparza Extension for Certain Advanced Breast Cancer Patients
  • Arena Pharmaceutical’s Ralinepag Shows Promise in Treating PAH in Phase 2 Clinical Trial
  • Trovagene’s PCM-075 Increases Zytiga’s Punch Against Prostate Cancer, Studies Show
  • Latest Clinical Data Presented on GS010 for Mitochondria Disease of the Eyes
  • Ovarian Cancer Gene Therapy Specialist Is One of Three Researchers Sharing $1.3 Million in Grants
  • Type of Multiple Myeloma May Affect Responses to Darzalex, Study Finds
  • Amgen and CytomX Therapeutics Announce Partnership for Immuno-Oncology Research
  • LFA Appoints New Chair of Medical-Scientific Advisory Council
  • Interview: RECAP Trial Confirms Esbriet’s Long-Term Safety Profile
  • MIT Researchers Use Genome Editing to Seek Genes that Protect Against Parkinson’s